Thursday, April 23, 2026

TRENT BTST - No Buy

IF the largest single OI change in the entire chain is put long UNWINDING at a strike well below spot — THEN as a buyer, read this as a capitulation signal, not a floor-building signal. Today's TRENT chain had −1,094 OI change at 4,000 PE — the single biggest number in the whole sheet. Bears who bought puts expecting TRENT to fall to 4,000 gave up and closed their positions in size. This is different from put writing (which is institutional conviction that a level holds). Put long unwinding says: I was wrong, I'm out. When the largest bearish position in a chain exits, it removes a structural weight from the stock. As a buyer, this is a subtle but powerful signal — not because bulls are building, but because the last big seller just left the room. The rule: scan the put side not just for writing (positive OI change) but also for large unwinding (negative OI change). Large put long exits are a secondary bullish signal — they confirm the directional lean but don't drive it alone. Pair it with at least one call-side signal before acting.

INFY - Going nowhere tomorrow

IF fresh call OI builds up at a strike that is less than 1.5% above the current spot price AND put OI builds up symmetrically below spot — THEN as a buyer, you are looking at a pinning setup, not a breakout setup. Today's INFY chain is the textbook example. The 1,260 CE wall is only ₹18 above a ₹1,242 spot — that's 1.4%. When market makers and institutions install a call wall this close to spot, they are explicitly saying: we expect this stock to go nowhere tomorrow. For a buyer, the breakeven on a 1,260 CE (premium ₹24) is ₹1,284 — which is already above the next wall at ₹1,300. You need the stock to blast through two walls just to make money. The rule: distance between spot and the nearest call wall must be at least 2–3% for a call buy to have structural room to breathe. When the wall is closer than 1.5%, the trade is structurally compromised before you even dial the broker. Look at the gap first, then the OI direction.



OFSS - No Buy

IF call short covering dominates the chain above spot AND put writing dominates below spot — but IV is sitting at 1.5x its normal range — THEN as a buyer, the OI structure is telling you the direction, but the IV is telling you the market has already priced in the move. Today's OFSS chain is a masterclass in this trap. Every OI signal screamed bullish: walls cracking at 8,100–8,500, floors being built at 8,500 PE, bears unwinding at 7,000–7,500 PE. Yet IV at 38% on a stock that normally trades 22% means you are buying the most expensive option of the quarter — right before a results event that will collapse IV regardless of outcome. The rule to tattoo in your playbook: OI tells you direction; IV tells you price. You need both to align. When direction is right but price is wrong, you sit out — and wait for IV to revert before buying. Post-results, if OFSS holds above 8,500 and IV drops back to 22–25%, that's the real entry for next week's trade.

DRREDDY BTST

IF you see put writing concentrated AT-THE-MONEY (not just below spot, but right at current spot price) — today DRREDDY 1,300 PE saw +1,077 fresh contracts written when spot was ₹1,328, making this essentially an at-the-money floor — THEN as a buyer, this is your highest-conviction bullish signal in the entire chain. Put writers at-the-money are taking on maximum risk: if the stock falls even ₹30, their short puts go deeply in-the-money. They only do this when they are extremely confident the stock will not fall. As a buyer, when you see put writing at spot rather than safely below it, the institutional conviction level is telling you something the price chart isn't yet showing. The closer the put writing is to the current spot, the stronger the bullish floor signal — and the tighter your stop-loss can be, because you know exactly where the institutional pain point is. 

Tuesday, April 21, 2026

THE OPTIONS BUYER'S PLAYBOOK

THE OPTIONS BUYER'S PLAYBOOK 

Lesson 1 — Read the index before any stock. IF the screener shows an index (NIFTY/BANKNIFTY/FINNIFTY) with an OI spurt 3–5× higher than most stocks, THEN read the index chain first. Institutions move the index before stocks reprice. Your stock pick should confirm what the index is already saying.

Lesson 2 — Expiry day OI is noise, not signal. IF today is expiry day and the screener shows a massive OI spike on an index, THEN ignore it entirely for BTST. That OI is settlement and pinning activity, not fresh directional positioning. You need the next-expiry chain. Without it, there is no trade.

Lesson 3 — Below 2:1 call-to-put ratio, sit out. IF the call-to-put OI ratio in the actionable zone around spot is below 2:1, THEN do not buy — even if the directional bias looks mildly bullish. When writers on both sides are equally active, the underlying goes nowhere and theta bleeds you daily. The 2:1 rule exists to filter ambiguous days. Preservation here funds your high-conviction trades.

Lesson 4 — Old ceiling gone, new ceiling installed = wait, not buy. IF call short covering is happening at strikes below spot AND fresh call writing is simultaneously appearing at strikes above spot in the same session, THEN this is consolidation, not breakout. The old resistance cleared but new resistance was immediately installed at a higher level. Wait for the new ceiling to start covering before you buy calls.

Lesson 5 — Multi-strike call covering + put writing ladder = strongest buy signal. IF call short covering is happening across 4–5 consecutive strikes above spot AND an ascending put writing ladder is being built below spot in the same session, THEN buy calls at half-size minimum — even if the absolute call-to-put ratio is below 2:1. Single-strike covering is one player. Five-strike covering is an institutional bear retreat. Paired with a put writing ladder, this is the highest-conviction bullish pattern a chain can show.

Monday, November 3, 2025

Prediction Report — India Equity Markets (4 Nov 2025, IST)

What’s happening?

So here’s the thing — global cues are giving a mixed vibe. On one hand, optimism around a possible U.S.–China tariff truce is helping Asian markets inch up. On the other, European futures are muted and look like they’re waiting for catalysts. Domestically, we’re seeing some caution: the “fear gauge”, India VIX, hasn’t collapsed — it’s elevated, signalling that market participants expect some bumps ahead. 

At the same time:

  • Domestic Institutional Investors (DIIs) are providing some support, which gives a floor.

  • The USD/INR pair is stabilising, which reduces one layer of external risk.

  • But profit-booking is happening after recent gains, so the market isn’t charging ahead full steam.

  • There’s sector rotation in the air — defensive names are getting eyeballs amid geopolitical jitters.

Because this isn’t just “markets up or down”. It’s a conditional scenario. If the major index (Nifty 50) can hold above the ~25,700 mark, there’s room for a mildly bullish move — but if that fails, all bets are off and we could face more sideways or even soft action.

The trading range we’re watching: 25,600 to 25,900. Inside that, there’ll be opportunities, but also risk of false breakouts.

The elevated VIX tells us: More volatility → Means you can’t just “set and forget” your positions. Even if the trend is mildly positive, the ride may have more twists.

What does this mean for businesses / sectors?

  • Defensives (think utilities, consumer staples) get preference in this kind of environment where fear is creeping in. Investors may lean away from high-beta, “let’s sprint” sectors.

  • Sector rotation is key. If flows start moving out of growth/risk-on sectors into safe plays, there may be short-term divergence (some sectors up, some down) rather than a broad market move.

  • FII positioning (= foreign institutional investors) matters for intraday swings. With global uncertainty high, their net flows can create sharp directional moves even if macro is steady.

  • For mid/small-cap businesses, caution is warranted. With volatility up and profit-booking around, they may face more pressure than large-caps.

Risks?

  • If Nifty dips below ~25,700 decisively, the mildly bullish bias vanishes — the market could drift or even cede ground.

  • External shocks (geopolitical flare-ups, global growth concerns) could spike volatility and pull markets back.

  • Domestic earnings disappointments or macro surprises (e.g., inflation, interest rates) could undercut sentiment quickly.

  • The elevated VIX suggests that sudden moves (both up and down) are more likely than in calmer times.

What’s our bias?

Mildly bullish — with a caveat. The market can grind higher provided that key support holds. But it’s not a full-throttle rally mode. Think of it like cautiously optimistic: you’re driving the car, foot on the gas, but with your hand hovering over the brake too.

Target wise: If things line up, we could see the Nifty push toward ~25,900. If support fails, we’re looking at ~25,600 as a critical floor.

If you’re an investor or trader:

  • For existing positions: Tighten your stop-losses a little. Volatility is higher — you don’t want a big surprise knocking you off.

  • For new buys: Focus on high-quality names, especially in defensives or sectors where earnings are steady. Avoid chasing high-flyers just because “they’ll bounce”.

  • On timing: The range of ~25,600-25,900 is your arena. If you see a strong breakout above ~25,900 with conviction, it’s a green light. If you see a break below ~25,700, hit pause, reassess.

  • Stay nimble: Because the elevated VIX says risk is real — treat this as a trading environment more than a “set-and-hold for months” regime.

Friday, July 11, 2025

The Glenmark Pharmaceuticals Case Study

 

Understanding Stock Analysis: 

How a single announcement can transform a stock's trajectory and what investors can learn from technical analysis.

On July 11, 2025, Glenmark Pharmaceuticals provided investors with a masterclass in how fundamental catalysts can drive extraordinary stock movements. The Indian pharmaceutical company's shares surged an unprecedented 14.55% in a single trading session. This dramatic move offers valuable lessons for investors about stock analysis, market dynamics, and the importance of understanding both fundamental and technical factors.

The Catalyst: When Innovation Meets Opportunity

The trigger for this remarkable surge was Glenmark's announcement of a licensing deal with global pharmaceutical giant AbbVie. The agreement involves ISB 2001, a cancer treatment developed by Glenmark's subsidiary, with AbbVie paying 700 million USD upfront. 

This represents the largest biotechnology licensing deal ever signed by an Indian company, validating the country's growing capabilities in innovative drug development.

For investors, this highlights a crucial lesson: fundamental analysis isn't just about quarterly earnings and revenue growth. Sometimes, the most significant value drivers come from strategic developments that can reshape a company's entire future trajectory. Glenmark's years of investment in research and development, which may have seemed costly to some investors, suddenly proved their worth in spectacular fashion.

Reading the Technical Signals

From a technical analysis perspective, Glenmark's chart tells a fascinating story. The stock exhibited several key indicators that sophisticated investors monitor:

Volume Confirmation: The day's trading volume of 15.68 million shares represented an 8.3x increase over normal levels. In technical analysis, volume confirms price movements. When a stock makes a significant move on heavy volume, it suggests genuine institutional interest rather than speculative trading.
Momentum Indicators: The Relative Strength Index (RSI) reached 89.8, well into overbought territory. While this might typically signal caution, during strong fundamental-driven moves, stocks can remain overbought for extended periods. The key is understanding the context behind the technical readings.



Price Prediction and Risk Management

Based on comprehensive analysis combining fundamental catalysts with technical indicators, the probability-weighted outlook for the next 3-5 trading days suggests a 70.6% chance of continued bullish momentum. Price targets range from ₹2,072 (conservative) to ₹2,508 (optimistic), with a base case target of ₹2,300.

However, successful investing requires acknowledging risks alongside opportunities. The extreme overbought technical conditions suggest potential volatility ahead. Smart investors might consider position sizing carefully and implementing stop-loss levels around ₹1,950-2,000 to protect against significant reversals.

Key Takeaways for Investors

This case study demonstrates several important principles. First, fundamental analysis and technical analysis work best when used together, not in isolation. Second, extraordinary moves often require extraordinary catalysts – random price spikes without underlying reasons rarely sustain. Third, volume analysis provides crucial confirmation of price movements' legitimacy.

Most importantly, Glenmark's story illustrates how companies that invest consistently in innovation can create transformational value for shareholders. While not every research investment pays off, when breakthrough moments arrive, they can more than compensate for years of patient capital allocation.
For investors, the lesson is clear: understanding both the fundamental drivers and technical dynamics of stock movements provides the best framework for making informed investment decisions in an ever-changing market landscape.

TRENT BTST - No Buy

IF the largest single OI change in the entire chain is put long UNWINDING at a strike well below spot — THEN as a buyer, read this as a capi...